What's new in human papillomavirus, infection

Current Opinion in Pediatrics

Volumn 12, Issue 4, 2000, Pages 365-369

  Allen, Angel L ^a   Siegfried, Elaine C ^a  

^a S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CANDIDA ANTIGEN; CANTHARIDIN; CIDOFOVIR; CIMETIDINE; DIPHENCYPRONE; FORMALDEHYDE; GLUTARALDEHYDE; IMIQUIMOD; PODOPHYLLOTOXIN; SALICYLIC ACID; SQUARIC ACID DERIVATIVE;

ALTERNATIVE MEDICINE; ANTIVIRAL ACTIVITY; CHILD; CONTACT SENSITIZATION; CRYOTHERAPY; CURETTAGE; ELECTROSURGERY; HUMAN; HYPNOSIS; IMMUNE RESPONSE; PRIORITY JOURNAL; REVIEW; VERRUCA VULGARIS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; AMINOQUINOLINES; CHILD; CIMETIDINE; CYTOSINE; HISTAMINE H2 ANTAGONISTS; HUMANS; HYPNOSIS; KERATOLYTIC AGENTS; ORGANOPHOSPHORUS COMPOUNDS; PAPILLOMAVIRIDAE; PHOSPHONIC ACIDS; PODOPHYLLOTOXIN; RECURRENCE; RISK FACTORS; WARTS;

EID: 0033926536     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200008000-00015     Document Type: Review

References (44)

1. 1 Liang MH: From America: cookbook medicine of food for thought: practice guidelines development in the USA. Ann Rheum Dis 1992, 51:1257-1258.
2. 2 Massing AM, Estonia WL: Natural history of warts: a two year study. Arch Dermatol 1963, 87:306-310.
3. 3 Allen AL, Siegfried EC: The natural history of condyloma in children. J Am Acad Dermatol 1998, 39:951-955.
4. 4 Siegfried EC: Warts and molluscum on children-an approach to therapy. Dermatol Therapy 1997, 2:51-67.
5. 5 Ewin DM Hypnotherapy for warts (verruca vulgaris): 41 consecutive cases with 33 cures. Am J Clin Hypnosis 1992, 35:1-10.
6. 6 Olnes K: Cyberphysiologic strategies in pediatric practice (biofeedback, self-hypnosis, and relaxation training). Pediatr Ann 1991, 20:115-119.
7. 7 Litt JZ: Dermatologic dozen. In Your Skin and How to Live in it. Cleveland, OH: The Corinthian Press; 1980:30-31.
8. 8 Jorizzo, Sams WM, Jegasothy BV, et al.: Cimetidine as an immunomodulator: chronic mucocutaneous candidiasis as a model. Ann Intern Med 1980, 92:192-195.
9. 9 White WB, Ballow M: Modulation of suppressor-cell activity by cimetidine in patients with common variable hypogammaglobulinemia. N Engl J Med 1985, 312:198-202.
10. 10 Ben-Joseph R, Segal R, Russell WL: Common variable immunodeficiency: a family study and therapeutic trial with cimetidine. J Allergy Clin Immunol 1989, 84:753-761.
11. 11 Simon GL, Miller HG, Scott SJ: Cimetidine in the treatment of hypenmmunoglobulinemia E in impaired chemotaxis. J Infect Dis 1983, 147:1121-1122.
12. 12 Mavligit GM, Talpaz M: Cimetidine for herpes zoster. N Engl J Med 1984, 310:318-319.
13. 13 Cohen PR, Kurzrock R: Herpes simplex virus infections and cimetidine therapy. J Am Acad Dermatol 1988, 19:762-763.
14. 14 Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996, 383:787-793.
15. 5 Elenkov IJ, Webster E, Papanicolaou DA, et al.: Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol 1998, 161:2586-2593.
16. 16 Orlow SJ, Paller A: Cimetidine therapy for multiple viral warts in children. J Am Acad Dermatol 1993, 28:794-796.
17. 17 Fischer G, Rogers M: Cimetidine therapy for warts in children. J Am Acad Dermatol 1997, 37:289-290.
18. 18 Rogers CJ, Gibney MD, Siegfried EC, et al.: Cimetidine therapy for recalcitrant warts in adults: is it any better than placebo? J Am Acad Dermatol 1999, 41:123-127. This comprehensive review of the efficacy of cimetidine therapy for recalcitrant warts includes the authors' own double-blinded, placebo-controlled study of cimetidine use in adults with recalcitrant warts. This study had the most stringent enrollment criteria to date and found that five of 19 (25%) subjects in the active group had clearing of their warts, compared with only one of 21 (5%) in the control group.
19. 19 Bauman C, Francis JS, Vanderhooft S, et al.: Cimetidine therapy for multiple viral warts in children. J Am Acad Dermatol 1996, 35:271-272.
20. 20 Saenz-Santamarie MC, Gilaberte Y: Cimetidine and warts. Arch Dermatol 1997, 133:530-531.
21. 21 Lewis HM: Topical immunotherapy of refractory warts. Cutis 1973, 12:863-867.
22. 22 Lever's Histopathology of the Skin, edn 8. Edited by Elder D, Elenitsas R, Jaworsky J, et al. Philadelphia, PA: Lippincott-Raven; 1997:212-213.
23. 23 Lee AN, Mallory SB: Contact immunotherapy with squaric acid dibutylester for the treatment of recalcitrant warts. J Am Acad Dermatol 1999, 41:595-599. This is a prospective open label study of SADBE in the treatment of recalcitrant warts in a primarily pediatric population that included 12 patients (40% of 29) who were receiving concurrent adjunctive therapy, including cryotherapy, salicylic acid, soaking, paring, and cimetidine.
24. 24 Iijima S, Otsuka F: Contact immunotherapy with squaric acid dibutylester for warts. Dermatology 1993, 187:115-118.
25. 25 Claudy AL, Roch H: Traitement des verrues multiples et recidivantes par induction d'une hypersensibilite retardee: II: étude critique de l'utilisation du dibutylester de l'acide squarique. Ann Dermatol Venereol 1981, 108:765-767.
26. 26 Hull SM, Cunliffe WJ: Treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol 1992, 26:276-277.
27. 27 Buckley DA, Keane FM, Munn SE, et al.: Recalcitrant viral warts treated by diphencyprone immunotherapy. Br J Dermatol 1999. 141:292-296. This open label study showed a high response rate of recalcitrant warts to DCP, but the criteria for enrollment were not stringent.
28. 28 Rampen FHJ, Steijien PM: Diphencyprone in the management of refractory palmoplantar and periungual warts: an open study. Dermatol 1996, 193:236-238.
29. 29 Wiesner-Menzel L, Happle R: Rückbildung von Plantarwarzen nach Behandlung mit Diphencyprone. Z Hautkr 1984, 59:1080-1083.
30. 30 Wardropper A, Woolley P: Treatment of anogenital warts in genitourinary clinics in England and Wales. Int J Sex Transm Dis AIDS 1992, 3:439-441.
31. 31 Ellenhorn MJ: Podophyllum. In Poisondex system. Edited by Rumack BH, Hess AJ. Englewood, CO: Micromedex; 1996.
32. 32 Link MR: Therapy of genital human papillomavirus infections: II: methods of treatment. Int J Dermatol 1992, 31:769-776.
33. 33 Perry CM, Lamb HM: Topical imiquimod: a review of its use in genital warts. Drugs 1999, 58:375-390. This is a comprehensive review of published data on the mechanisms, efficacy, and side effects associated with imiquimod in the treatment of genital warts.
34. 34 Beutner K, Spruance SL, Hougham AJ, et al.: Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol 1998, 38:230-239.
35. 35 Syed TA, Goswami J, Ahmadpour OA, et al.: Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: a placebo-controlled, double-blind study. J Dermatol 1998, 25:309-313.
36. 36 Beutner KR, Tyring SK, Trofatter KF Jr: Imiquimod, a patien-applied immune-response modifier for treatment of external genital warts. Antimicrob Agents Chemother 1998, 42:789-794.
37. 7 Snoeck R, Ranst MV, Andrei G, et al.: Treatment of anogenital papillomavirus infections with an acyclic nucleoside phosphonate analogue [letter]. New Engl J Med 1995, 333:943.
38. 38 Zabawski EJ, Sands B, Goetz D, et al.: Treatment of verruca vulgaris with topical cidofovir [letter]. JAMA 1997, 278:1236.
39. 39 Zabawski EJ, Cockerell CJ: Topical and intralesional cidofovir: A review of pharmacology and therapeutic effects. J Am Acad Dermatol 1998, 39:742-745.
40. 40 Anonymous: Cidofovir. In Poisondex System. Edited by Rumack BH, Hess AJ. Englewood, CO: Micromedex; 1999. This is an invaluable source of reference for extensive data on dosing, contraindications, and adverse reactions of medications.
41. 41 Bolton R: A warty problem. Cortlandt Letters. September 1999; 139:124.
42. 42 Haller K: Candida antigen injection resolves common warts. Proceedings of the American Academy of Family Physicians 1999. Orlando: American Academy of Family Physicians; 1999. A double-blind placebo controlled study of intralesional Candida antigen injection with a high response rate. The details of this study have not been published.
43. 43 Clinical ecology. American College of Physicians. Ann Intern Med 1989, 111:542.
44. 44 Sandven P: Candida albicans-is it causing a new national disease? Tidsskrift for Den Norske Laegeforening 1989, 109:357-360.